Last 12 months
Inside the activity.
2 purchase rows · 30 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 2 | 3 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 3 |
| Jun 2026 | 0 | 5 |
| Jul 2026 | 0 | 4 |
| Aug 2026 | 0 | 7 |
| Sep 2026 | 0 | 5 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 08, 2026 Filed May 11, 2026 23:13 UTC |
FOLETTA MARK GDirector
|
GiftCommon Stock | 5,731 | $0.00 | $0.00 |
DisclosureSEC source: 0001093557-26-000079 · wk-form4_1778541186.xml · nonDerivative · entry 1 FOLETTA MARK G · CIK 0001236389 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · shares: Shares were transferred from direct ownership to ownership under the Mark G. and Mary E. Foletta, TTEE's for the Foletta Family Trust DTD 1/30/15, upon vesting of previously awarded restricted stock units. Read SEC document |
| May 08, 2026 Filed May 11, 2026 23:13 UTC |
ALTMAN STEVEN RDirector
|
GiftCommon Stock | 5,037 | $0.00 | $0.00 |
DisclosureSEC source: 0001093557-26-000078 · wk-form4_1778541180.xml · nonDerivative · entry 2 ALTMAN STEVEN R · CIK 0001191307 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · by Trust Disclosed balance after: 63,667 F1 · shares: Shares were transferred from direct ownership to ownership under the Steven R. and Lisa J. Altman, TTEE's Altman Family Trust DTD 8/21/92, upon vesting of previously awarded restricted stock units. F2 · ownership.nature: Shares are held by the Steven R. and Lisa J. Altman, TTEE's Altman Family Trust DTD 8/21/92, with respect to which the reporting person is a trustee. Read SEC document |
| May 08, 2026 Filed May 11, 2026 23:13 UTC |
ALTMAN STEVEN RDirector
|
GiftCommon Stock | 5,037 | $0.00 | $0.00 |
DisclosureSEC source: 0001093557-26-000078 · wk-form4_1778541180.xml · nonDerivative · entry 1 ALTMAN STEVEN R · CIK 0001191307 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · shares: Shares were transferred from direct ownership to ownership under the Steven R. and Lisa J. Altman, TTEE's Altman Family Trust DTD 8/21/92, upon vesting of previously awarded restricted stock units. Read SEC document |
| April 15, 2026 Filed Apr 16, 2026 23:27 UTC |
Brown Michael JonEVP, Chief Legal Officer
|
SaleCommon Stock | 1,700 | $63.04 | $107,168.00 |
DisclosureSEC source: 0001093557-26-000065 · wk-form4_1776382026.xml · nonDerivative · entry 1 Brown Michael Jon · CIK 0001899922 · EVP, Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 111,204 F1 · shares: On November 26, 2025, Mr. Brown adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Brown. The shares set forth above were sold pursuant to the 10b5- 1 Plan. F2 · balance_after: Included in this number are 77,603 unvested RSUs, 39,019 of which were granted on March 8, 2026 and shall vest through March 8, 2029, 19,948 of which were granted on March 8, 2025 and shall vest through March 8, 2028, 11,399 of which were granted on March 8, 2025 and shall vest through March 8, 2027, and 7,237 of which were granted on March 8, 2024 and shall vest through March 8, 2027. Read SEC document |
| March 16, 2026 Filed Mar 18, 2026 20:07 UTC |
Brown Michael JonEVP, Chief Legal Officer
|
SaleCommon Stock | 1,700 | $64.85 | $110,245.00 |
DisclosureSEC source: 0001093557-26-000052 · wk-form4_1773864421.xml · nonDerivative · entry 1 Brown Michael Jon · CIK 0001899922 · EVP, Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 112,904 F1 · shares: On November 26, 2025, Mr. Brown adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Brown. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 77,603 unvested restricted stock units, 39,019 of which were granted on March 8, 2026 and shall vest through March 8, 2029, 19,948 of which were granted on March 8, 2025 and shall vest through March 8, 2028, 11,399 of which were granted on March 8, 2025 and shall vest through March 8, 2027, and 7,237 of which were granted on March 8, 2024 and shall vest through March 8, 2027. Read SEC document |
| March 08, 2026 Filed Mar 10, 2026 20:02 UTC |
SAYER KEVIN RDirector · Executive Chair
|
Tax withholdingCommon Stock | 32,498 | $68.10 | $2,213,113.80 |
DisclosureSEC source: 0001093557-26-000050 · wk-form4_1773172919.xml · nonDerivative · entry 2 SAYER KEVIN R · CIK 0001286858 · Director · Executive Chair 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 409,241 F2 · shares: Represents the number of shares required to be withheld by the Issuer to cover tax withholding and remittance obligations in connection with the net settlement of RSUs and does not represent a sale by the Reporting Person. F3 · balance_after: Included in this number are 106,972 unvested RSUs, 32,749 of which were granted on March 8, 2026 and shall vest on March 8, 2027, 56,993 of which were granted on March 8, 2025 and shall vest through March 8, 2028, and 17,230 of which were granted on March 8, 2024 and shall vest through March 8, 2027. Read SEC document |
| March 08, 2026 Filed Mar 10, 2026 20:02 UTC |
SAYER KEVIN RDirector · Executive Chair
|
GrantCommon Stock | 32,749 | $0.00 | $0.00 |
DisclosureSEC source: 0001093557-26-000050 · wk-form4_1773172919.xml · nonDerivative · entry 1 SAYER KEVIN R · CIK 0001286858 · Director · Executive Chair 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 441,739 F1 · shares: Represents a grant of restricted stock units (RSUs) that are exempt from Section 16b-3 and are subject to vesting on the one year anniversary of the date of grant. RSUs represent a contingent right to receive one share of DexCom, Inc. Common Stock. Read SEC document |
| March 08, 2026 Filed Mar 10, 2026 20:01 UTC |
Sylvain Jereme MEVP, Chief Financal Officer
|
Tax withholdingCommon Stock | 18,950 | $68.10 | $1,290,495.00 |
DisclosureSEC source: 0001093557-26-000049 · wk-form4_1773172914.xml · nonDerivative · entry 2 Sylvain Jereme M · CIK 0001681267 · EVP, Chief Financal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 153,292 F2 · shares: Represents the number of shares required to be withheld by the Issuer to cover tax withholding and remittance obligations in connection with the net settlement of RSUs and does not represent a sale by the Reporting Person. F3 · balance_after: Included in this number are 92,794 unvested RSUs, 48,774 of which were granted on March 8, 2026 and shall vest through March 8, 2029, 23,937 of which were granted on March 8, 2025 and shall vest through March 8, 2028, 11,399 of which were granted on March 8, 2025 and shall vest through March 8, 2027, 8,684 of which were granted on March 8, 2024 and shall vest through March 8, 2027, and 261 additional shares acquired under the Issuer's Amended and Restated 2015 Employee Stock Purchase Plan. Read SEC document |
| March 08, 2026 Filed Mar 10, 2026 20:01 UTC |
Sylvain Jereme MEVP, Chief Financal Officer
|
GrantCommon Stock | 48,774 | $0.00 | $0.00 |
DisclosureSEC source: 0001093557-26-000049 · wk-form4_1773172914.xml · nonDerivative · entry 1 Sylvain Jereme M · CIK 0001681267 · EVP, Chief Financal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 172,242 F1 · shares: Represents a grant of restricted stock units (RSUs) that are exempt from Section 16b-3 and are subject to vesting in three equal annual installments from the date of grant. RSUs represent a contingent right to receive one share of DexCom, Inc. Common Stock. Read SEC document |
| March 08, 2026 Filed Mar 10, 2026 20:01 UTC |
Brown Michael JonEVP, Chief Legal Officer
|
Tax withholdingCommon Stock | 23,325 | $68.10 | $1,588,432.50 |
DisclosureSEC source: 0001093557-26-000048 · wk-form4_1773172906.xml · nonDerivative · entry 2 Brown Michael Jon · CIK 0001899922 · EVP, Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 114,604 F2 · shares: Represents the number of shares required to be withheld by the Issuer to cover tax withholding and remittance obligations in connection with the net settlement of RSUs and does not represent a sale by the Reporting Person. F3 · balance_after: Included in this number are 77,603 unvested RSUs, 39,019 of which were granted on March 8, 2026 and shall vest through March 8, 2029, 19,948 of which were granted on March 8, 2025 and shall vest through March 8, 2028, 11,399 of which were granted on March 8, 2025 and shall vest through March 8, 2027, 7,237 of which were granted on March 8, 2024 and shall vest through March 8, 2027, and 255 additional shares acquired under the Issuer's Amended and Restated 2015 Employee Stock Purchase Plan. Read SEC document |
| March 08, 2026 Filed Mar 10, 2026 20:01 UTC |
Brown Michael JonEVP, Chief Legal Officer
|
GrantCommon Stock | 39,019 | $0.00 | $0.00 |
DisclosureSEC source: 0001093557-26-000048 · wk-form4_1773172906.xml · nonDerivative · entry 1 Brown Michael Jon · CIK 0001899922 · EVP, Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 137,929 F1 · shares: Represents a grant of restricted stock units (RSUs) that are exempt from Section 16b-3 and are subject to vesting in three equal annual installments from the date of grant. RSUs represent a contingent right to receive one share of DexCom, Inc. Common Stock. Read SEC document |
| March 08, 2026 Filed Mar 10, 2026 20:01 UTC |
Stern SadieEVP, Chief HR Officer
|
Tax withholdingCommon Stock | 17,199 | $68.10 | $1,171,251.90 |
DisclosureSEC source: 0001093557-26-000047 · wk-form4_1773172900.xml · nonDerivative · entry 2 Stern Sadie · CIK 0001797971 · EVP, Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 131,510 F2 · shares: Represents the number of shares required to be withheld by the Issuer to cover tax withholding and remittance obligations in connection with the net settlement of RSUs and does not represent a sale by the Reporting Person. F3 · balance_after: Included in this number are 77,603 unvested RSUs, 39,019 of which were granted on March 8, 2026 and shall vest through March 8, 2029, 19,948 of which were granted on March 8, 2025 and shall vest through March 8, 2028, 11,399 of which were granted on March 8, 2025 and shall vest through March 8, 2027, and 7,237 of which were granted on March 8, 2024 and shall vest through March 8, 2027. Read SEC document |
| March 08, 2026 Filed Mar 10, 2026 20:01 UTC |
Stern SadieEVP, Chief HR Officer
|
GrantCommon Stock | 39,019 | $0.00 | $0.00 |
DisclosureSEC source: 0001093557-26-000047 · wk-form4_1773172900.xml · nonDerivative · entry 1 Stern Sadie · CIK 0001797971 · EVP, Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 148,709 F1 · shares: Represents a grant of restricted stock units (RSUs) that are exempt from Section 16b-3 and are subject to vesting in three equal annual installments from the date of grant. RSUs represent a contingent right to receive one share of DexCom, Inc. Common Stock. Read SEC document |
| March 08, 2026 Filed Mar 10, 2026 20:01 UTC |
Leach Jacob StevenDirector · President, CEO, and Director
|
Tax withholdingCommon Stock | 19,757 | $68.10 | $1,345,451.70 |
DisclosureSEC source: 0001093557-26-000046 · wk-form4_1773172894.xml · nonDerivative · entry 2 Leach Jacob Steven · CIK 0001700255 · Director · President, CEO, and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 421,810 F2 · shares: Represents the number of shares required to be withheld by the Issuer to cover tax withholding and remittance obligations in connection with the net settlement of RSUs and does not represent a sale by the Reporting Person. F3 · balance_after: Included in this number are 148,536 unvested RSUs, 104,516 of which were granted on March 8, 2026 and shall vest through March 8, 2029, 23,937 of which were granted on March 8, 2025 and shall vest through March 8, 2028, 11,399 of which were granted on March 8, 2025 and shall vest through March 8, 2027, and 8,684 of which were granted on March 8, 2024 and shall vest through March 8, 2027. Read SEC document |
| March 08, 2026 Filed Mar 10, 2026 20:01 UTC |
Leach Jacob StevenDirector · President, CEO, and Director
|
GrantCommon Stock | 104,516 | $0.00 | $0.00 |
DisclosureSEC source: 0001093557-26-000046 · wk-form4_1773172894.xml · nonDerivative · entry 1 Leach Jacob Steven · CIK 0001700255 · Director · President, CEO, and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 441,567 F1 · shares: Represents a grant of restricted stock units (RSUs) that are exempt from Section 16b-3 and are subject to vesting in three equal annual installments from the date of grant. RSUs represent a contingent right to receive one share of DexCom, Inc. Common Stock. Read SEC document |
| March 08, 2026 Filed Mar 10, 2026 20:01 UTC |
Coleman JonEVP, Chief Commercial Officer
|
GrantCommon Stock | 43,897 | $0.00 | $0.00 |
DisclosureSEC source: 0001093557-26-000045 · wk-form4_1773172888.xml · nonDerivative · entry 1 Coleman Jon · CIK 0001442689 · EVP, Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 112,635 F1 · shares: Represents a grant of restricted stock units (RSUs) that are exempt from Section 16b-3 and are subject to vesting in three equal annual installments from the date of grant. RSUs represent a contingent right to receive one share of DexCom, Inc. Common Stock. F2 · balance_after: Included in this number are 112,635 unvested RSUs, 43,897 of which were granted on March 8, 2026 and shall vest through March 8, 2029, and 68,738 of which were granted on May 22, 2025 and shall vest through May 22, 2029. Read SEC document |
| February 26, 2026 Filed Feb 26, 2026 21:32 UTC |
Osterloh Albert Frederick IVDirector
|
GrantCommon Stock | 7,061 | $0.00 | $0.00 |
DisclosureSEC source: 0001093557-26-000034 · wk-form4_1772141531.xml · nonDerivative · entry 1 Osterloh Albert Frederick IV · CIK 0002111108 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,061 F1 · shares: Represents a grant of restricted stock units that are exempt from Section 16b-3 and are subject to vesting in three equal annual installments from the date of grant. Restricted stock units represent a contingent right to receive one share of DexCom, Inc. Common Stock. Read SEC document |
| February 12, 2026 Filed Feb 17, 2026 21:36 UTC |
Heller Bridgette PDirector
|
SaleCommon Stock | 1,012 | $68.01 | $68,826.12 |
DisclosureSEC source: 0001485616-26-000002 · wk-form4_1771364201.xml · nonDerivative · entry 1 Heller Bridgette P · CIK 0001485616 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 26,019 F1 · shares: On August 14, 2025, Ms. Heller adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Ms. Heller. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 5,046 unvested restricted stock units which were granted on May 8, 2025 and will vest on the earlier of the one year anniversary of the grant date or the date of DexCom, Inc.'s 2026 Annual Meeting of Stockholders. Read SEC document |
| January 29, 2026 Filed Feb 2, 2026 21:46 UTC |
Leach Jacob StevenDirector · President, CEO, and Director
|
Tax withholdingCommon Stock | 3,058 | $73.36 | $224,334.88 |
DisclosureSEC source: 0001093557-26-000013 · wk-form4_1770068801.xml · nonDerivative · entry 2 Leach Jacob Steven · CIK 0001700255 · Director · President, CEO, and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 337,051 F2 · shares: Represents the number of shares required to be withheld by the Issuer to cover tax withholding and remittance obligations in connection with the net settlement of PSUs and does not represent a sale by the Reporting Person. F3 · balance_after: Included in this number are 84,537 unvested restricted stock units, 35,906 of which were granted on March 8, 2025 and shall vest through March 8, 2028, 22,798 of which were granted on March 8, 2025 and shall vest through March 8, 2027, 17,368 of which were granted on March 8, 2024 and shall vest through March 8, 2027, 8,465 of which were granted on March 8, 2023 and shall vest through March 8, 2026, and 102 additional shares acquired under the Issuer's Amended and Restated 2015 Employee Stock Purchase Plan. Read SEC document |
| January 29, 2026 Filed Feb 2, 2026 21:46 UTC |
Leach Jacob StevenDirector · President, CEO, and Director
|
GrantCommon Stock | 8,310 | $0.00 | $0.00 |
DisclosureSEC source: 0001093557-26-000013 · wk-form4_1770068801.xml · nonDerivative · entry 1 Leach Jacob Steven · CIK 0001700255 · Director · President, CEO, and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 340,109 F1 · shares: Represents shares issued to the Reporting Person upon vesting of performance-based restricted stock units (PSUs) granted to the Reporting Person on March 8, 2023, resulting from achievement of performance conditions under the PSUs. Read SEC document |
| January 29, 2026 Filed Feb 2, 2026 21:46 UTC |
Stern SadieEVP, Chief HR Officer
|
Tax withholdingCommon Stock | 2,656 | $73.36 | $194,844.16 |
DisclosureSEC source: 0001093557-26-000012 · wk-form4_1770068797.xml · nonDerivative · entry 2 Stern Sadie · CIK 0001797971 · EVP, Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 109,690 F2 · shares: Represents the number of shares required to be withheld by the Issuer to cover tax withholding and remittance obligations in connection with the net settlement of PSUs and does not represent a sale by the Reporting Person. F3 · balance_after: Included in this number are 74,450 unvested restricted stock units, 29,922 of which were granted on March 8, 2025 and shall vest through March 8, 2028, 22,798 of which were granted on March 8, 2025 and shall vest through March 8, 2027, 14,474 of which were granted on March 8, 2024 and shall vest through March 8, 2027, and 7,256 of which were granted on March 8, 2023 and shall vest through March 8, 2026. Read SEC document |
| January 29, 2026 Filed Feb 2, 2026 21:46 UTC |
Stern SadieEVP, Chief HR Officer
|
GrantCommon Stock | 7,123 | $0.00 | $0.00 |
DisclosureSEC source: 0001093557-26-000012 · wk-form4_1770068797.xml · nonDerivative · entry 1 Stern Sadie · CIK 0001797971 · EVP, Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 112,346 F1 · shares: Represents shares issued to the Reporting Person upon vesting of performance-based restricted stock units (PSUs) granted to the Reporting Person on March 8, 2023, resulting from achievement of performance conditions under the PSUs. Read SEC document |
| January 29, 2026 Filed Feb 2, 2026 21:46 UTC |
Sylvain Jereme MEVP, Chief Financal Officer
|
Tax withholdingCommon Stock | 2,652 | $73.36 | $194,550.72 |
DisclosureSEC source: 0001093557-26-000011 · wk-form4_1770068790.xml · nonDerivative · entry 2 Sylvain Jereme M · CIK 0001681267 · EVP, Chief Financal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 123,207 F2 · shares: Represents the number of shares required to be withheld by the Issuer to cover tax withholding and remittance obligations in connection with the net settlement of PSUs and does not represent a sale by the Reporting Person. F3 · balance_after: Included in this number are 83,328 unvested restricted stock units, 35,906 of which were granted on March 8, 2025 and shall vest through March 8, 2028, 22,798 of which were granted on March 8, 2025 and shall vest through March 8, 2027, 17,368 of which were granted on March 8, 2024 and shall vest through March 8, 2027, 7,256 of which were granted on March 8, 2023 and shall vest through March 8, 2026, and 79 additional shares acquired under the Issuer's Amended and Restated 2015 Employee Stock Purchase Plan. Read SEC document |
| January 29, 2026 Filed Feb 2, 2026 21:46 UTC |
Sylvain Jereme MEVP, Chief Financal Officer
|
GrantCommon Stock | 7,123 | $0.00 | $0.00 |
DisclosureSEC source: 0001093557-26-000011 · wk-form4_1770068790.xml · nonDerivative · entry 1 Sylvain Jereme M · CIK 0001681267 · EVP, Chief Financal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 125,859 F1 · shares: Represents shares issued to the Reporting Person upon vesting of performance-based restricted stock units (PSUs) granted to the Reporting Person on March 8, 2023, resulting from achievement of performance conditions under the PSUs. Read SEC document |
| January 29, 2026 Filed Feb 2, 2026 21:46 UTC |
Brown Michael JonEVP, Chief Legal Officer
|
Tax withholdingCommon Stock | 2,653 | $73.36 | $194,624.08 |
DisclosureSEC source: 0001093557-26-000010 · wk-form4_1770068784.xml · nonDerivative · entry 2 Brown Michael Jon · CIK 0001899922 · EVP, Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 98,655 F2 · shares: Represents the number of shares required to be withheld by the Issuer to cover tax withholding and remittance obligations in connection with the net settlement of PSUs and does not represent a sale by the Reporting Person. F3 · balance_after: Included in this number are 86,490 unvested restricted stock units, 29,922 of which were granted on March 8, 2025 and shall vest through March 8, 2028, 22,798 of which were granted on March 8, 2025 and shall vest through March 8, 2027, 14,474 of which were granted on March 8, 2024 and shall vest through March 8, 2027, 7,256 of which were granted on March 8, 2023 and shall vest through March 8, 2026, 12,040 of which were granted on March 8, 2022 and shall vest through March 8, 2026, and 83 additional shares acquired under the Issuer's Amended and Restated 2015 Employee Stock Purchase Plan. Read SEC document |
| January 29, 2026 Filed Feb 2, 2026 21:46 UTC |
Brown Michael JonEVP, Chief Legal Officer
|
GrantCommon Stock | 7,123 | $0.00 | $0.00 |
DisclosureSEC source: 0001093557-26-000010 · wk-form4_1770068784.xml · nonDerivative · entry 1 Brown Michael Jon · CIK 0001899922 · EVP, Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 101,308 F1 · shares: Represents shares issued to the Reporting Person upon vesting of performance-based restricted stock units (PSUs) granted to the Reporting Person on March 8, 2023, resulting from achievement of performance conditions under the PSUs. Read SEC document |
| January 29, 2026 Filed Feb 2, 2026 21:46 UTC |
SAYER KEVIN RDirector · Executive Chair
|
Tax withholdingCommon Stock | 34,257 | $73.36 | $2,513,093.52 |
DisclosureSEC source: 0001093557-26-000009 · wk-form4_1770068780.xml · nonDerivative · entry 2 SAYER KEVIN R · CIK 0001286858 · Director · Executive Chair 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 408,990 F2 · shares: Represents the number of shares required to be withheld by the Issuer to cover tax withholding and remittance obligations in connection with the net settlement of PSUs and does not represent a sale by the Reporting Person. F3 · balance_after: Included in this number are 138,091 unvested restricted stock units, 85,490 of which were granted on March 8, 2025 and shall vest through March 8, 2028, 34,461 of which were granted on March 8, 2024 and shall vest through March 8, 2027, and 18,140 of which were granted on March 9, 2023 and shall vest through March 8, 2026. Read SEC document |
| January 29, 2026 Filed Feb 2, 2026 21:46 UTC |
SAYER KEVIN RDirector · Executive Chair
|
GrantCommon Stock | 71,218 | $0.00 | $0.00 |
DisclosureSEC source: 0001093557-26-000009 · wk-form4_1770068780.xml · nonDerivative · entry 1 SAYER KEVIN R · CIK 0001286858 · Director · Executive Chair 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 443,247 F1 · shares: Represents shares issued to the Reporting Person upon vesting of performance-based restricted stock units (PSUs) granted to the Reporting Person on March 9, 2023, resulting from achievement of performance conditions under the PSUs. Read SEC document |
| November 14, 2025 Filed Nov 17, 2025 22:52 UTC |
Collins Richard AlexanderDirector
|
SaleCommon Stock | 2,906 | $59.05 | $171,599.30 |
DisclosureSEC source: 0001093557-25-000288 · wk-form4_1763419953.xml · nonDerivative · entry 1 Collins Richard Alexander · CIK 0001700619 · Director 10b5-1 filing: Plan reported Ownership: Indirect · by Trust Disclosed balance after: 35,088 F1 · shares: On August 7, 2025, the Richard A. Collins Revocable Trust (the "Trust") adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by the Trust. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · ownership.nature: Shares are held by the Richard A. Collins Revocable Trust, with respect to which the reporting person is a trustee. Read SEC document |
| November 12, 2025 Filed Nov 12, 2025 22:14 UTC |
Heller Bridgette PDirector
|
SaleCommon Stock | 1,012 | $58.07 | $58,766.84 |
DisclosureSEC source: 0001093557-25-000286 · wk-form4_1762985674.xml · nonDerivative · entry 1 Heller Bridgette P · CIK 0001485616 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 27,031 F1 · shares: On August 14, 2025, Ms. Heller adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Ms. Heller. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 5,046 unvested restricted stock units which were granted on May 8, 2025 and will vest on the earlier of the one year anniversary of the grant date or the date of DexCom, Inc.'s 2026 Annual Meeting of Stockholders. Read SEC document |
| November 10, 2025 Filed Nov 11, 2025 00:13 UTC |
Leach Jacob StevenPresident & COO
|
PurchaseCommon Stock | 2,500 | $55.43 | $138,563.00 |
DisclosureSEC source: 0001093557-25-000284 · wk-form4_1762819985.xml · nonDerivative · entry 2 Leach Jacob Steven · CIK 0001700255 · President & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 331,697 F2 · price: This transaction was executed in multiple trades at prices ranging from $55.34 to $55.55. The price above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 84,537 unvested restricted stock units, 35,906 of which were granted on March 8, 2025 and shall vest through March 8, 2028, 22,798 of which were granted on March 8, 2025 and shall vest through March 8, 2027, 17,368 of which were granted on March 8, 2024 and shall vest through March 8, 2027, and 8,465 of which were granted on March 8, 2023 and shall vest through March 8, 2026. Read SEC document |
| November 10, 2025 Filed Nov 11, 2025 00:13 UTC |
Leach Jacob StevenPresident & COO
|
PurchaseCommon Stock | 15,700 | $54.98 | $863,138.90 |
DisclosureSEC source: 0001093557-25-000284 · wk-form4_1762819985.xml · nonDerivative · entry 1 Leach Jacob Steven · CIK 0001700255 · President & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 329,197 F1 · price: This transaction was executed in multiple trades at prices ranging from $54.34 to $55.33. The price above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| November 10, 2025 Filed Nov 11, 2025 00:12 UTC |
Collins Richard AlexanderDirector
|
SaleCommon Stock | 3,948 | $55.17 | $217,811.16 |
DisclosureSEC source: 0001093557-25-000283 · wk-form4_1762819958.xml · nonDerivative · entry 1 Collins Richard Alexander · CIK 0001700619 · Director 10b5-1 filing: Plan reported Ownership: Indirect · by Trust Disclosed balance after: 37,994 F1 · shares: On August 7, 2025, the Richard A. Collins Revocable Trust (the "Trust") adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by the Trust. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · ownership.nature: Shares are held by the Richard A. Collins Revocable Trust, with respect to which the reporting person is a trustee. Read SEC document |
| October 24, 2025 Filed Oct 28, 2025 20:49 UTC |
Ashley Euan A.Director
|
GrantCommon Stock | 7,166 | $0.00 | $0.00 |
DisclosureSEC source: 0001093557-25-000271 · wk-form4_1761684559.xml · nonDerivative · entry 1 Ashley Euan A. · CIK 0002092523 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,166 F1 · shares: Represents a grant of restricted stock units that are exempt from Section 16b-3 and are subject to vesting in three equal annual installments from the date of grant. Restricted stock units represent a contingent right to receive one share of DexCom, Inc. Common Stock. Read SEC document |
| September 05, 2025 Filed Sep 9, 2025 20:18 UTC |
Malady KyleDirector
|
SaleCommon Stock | 667 | $80.86 | $53,933.62 |
DisclosureSEC source: 0001093557-25-000253 · wk-form4_1757449097.xml · nonDerivative · entry 1 Malady Kyle · CIK 0001760581 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 22,667 F1 · shares: On June 6, 2025, Mr. Malady adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Malady. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 5,192 unvested restricted stock units which were granted on May 8, 2025 and shall vest on the earlier of the one year anniversary of the grant date or the date of DexCom, Inc.'s 2026 Annual Meeting of Stockholders. Read SEC document |
| September 04, 2025 Filed Sep 8, 2025 20:06 UTC |
Stern SadieEVP, Chief HR Officer
|
SaleCommon Stock | 1,466 | $80.00 | $117,280.00 |
DisclosureSEC source: 0001093557-25-000251 · wk-form4_1757362012.xml · nonDerivative · entry 1 Stern Sadie · CIK 0001797971 · EVP, Chief HR Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 105,223 F1 · shares: On February 20, 2025, Ms. Stern adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Ms. Stern. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 74,450 unvested restricted stock units, 29,922 of which were granted on March 8, 2025 and shall vest through March 8, 2028, 22,798 of which were granted on March 8, 2025 and shall vest through March 8, 2027, 14,474 of which were granted on March 8, 2024 and shall vest through March 8, 2027, and 7,256 of which were granted on March 8, 2023 and shall vest through March 8, 2026. Read SEC document |
| September 02, 2025 Filed Sep 4, 2025 20:13 UTC |
Sylvain Jereme MEVP, Chief Financal Officer
|
SaleCommon Stock | 4,824 | $74.17 | $357,796.08 |
DisclosureSEC source: 0001093557-25-000249 · wk-form4_1757016814.xml · nonDerivative · entry 1 Sylvain Jereme M · CIK 0001681267 · EVP, Chief Financal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 118,657 F1 · shares: On May 27, 2025, Mr. Sylvain adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Sylvain. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 83,328 unvested restricted stock units, 35,906 of which were granted on March 8, 2025 and shall vest through March 8, 2028, 22,798 of which were granted on March 8, 2025 and shall vest through March 8, 2027, 17,368 of which were granted on March 8, 2024 and shall vest through March 8, 2027, and 7,256 of which were granted on March 8, 2023 and shall vest through March 8, 2026. Read SEC document |
| August 15, 2025 Filed Aug 18, 2025 21:53 UTC |
FOLETTA MARK GDirector
|
SaleCommon Stock | 195 | $81.54 | $15,900.30 |
DisclosureSEC source: 0001093557-25-000245 · wk-form4_1755553988.xml · nonDerivative · entry 2 FOLETTA MARK G · CIK 0001236389 · Director 10b5-1 filing: Plan reported Ownership: Indirect · by Trust Disclosed balance after: 51,121 F3 · ownership.nature: Shares are held by The Foletta Family Trust DTD 1/30/2015, with respect to which the reporting person is a trustee. Read SEC document |
| August 15, 2025 Filed Aug 18, 2025 21:53 UTC |
FOLETTA MARK GDirector
|
SaleCommon Stock | 2,555 | $81.02 | $207,002.52 |
DisclosureSEC source: 0001093557-25-000245 · wk-form4_1755553988.xml · nonDerivative · entry 1 FOLETTA MARK G · CIK 0001236389 · Director 10b5-1 filing: Plan reported Ownership: Indirect · by Trust Disclosed balance after: 51,316 F1 · shares: On March 13, 2025, The Foletta Family Trust DTD 1/30/2015 (the "Trust") adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by the Trust. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $80.29 to $81.22. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| August 15, 2025 Filed Aug 18, 2025 21:56 UTC |
Brown Michael JonEVP, Chief Legal Officer
|
SaleCommon Stock | 500 | $80.29 | $40,145.00 |
DisclosureSEC source: 0001093557-25-000247 · wk-form4_1755554185.xml · nonDerivative · entry 1 Brown Michael Jon · CIK 0001899922 · EVP, Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 94,102 F1 · shares: On February 21, 2025, Mr. Brown adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Brown. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 86,490 unvested restricted stock units, 29,922 of which were granted on March 8, 2025 and shall vest through March 8, 2028, 22,798 of which were granted on March 8, 2025 and shall vest through March 8, 2027, 14,474 of which were granted on March 8, 2024 and shall vest through March 8, 2027, 7,256 of which were granted on March 8, 2023 and shall vest through March 8, 2026, and 12,040 of which were granted on March 8, 2022 and shall vest through March 8, 2026. Read SEC document |
| July 28, 2025 Filed Jul 29, 2025 20:18 UTC |
Stern SadieEVP, Chief HR Officer
|
SaleCommon Stock | 1,466 | $88.99 | $130,459.34 |
DisclosureSEC source: 0001093557-25-000234 · wk-form4_1753820279.xml · nonDerivative · entry 1 Stern Sadie · CIK 0001797971 · EVP, Chief HR Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 106,689 F1 · shares: On February 20, 2025, Ms. Stern adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Ms. Stern. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 74,450 unvested restricted stock units, 29,922 of which were granted on March 8, 2025 and shall vest through March 8, 2028, 22,798 of which were granted on March 8, 2025 and shall vest through March 8, 2027, 14,474 of which were granted on March 8, 2024 and shall vest through March 8, 2027, and 7,256 of which were granted on March 8, 2023 and shall vest through March 8, 2026. Read SEC document |
| July 15, 2025 Filed Jul 17, 2025 20:08 UTC |
FOLETTA MARK GDirector
|
SaleCommon Stock | 8 | $86.03 | $688.24 |
DisclosureSEC source: 0001093557-25-000228 · wk-form4_1752782910.xml · nonDerivative · entry 2 FOLETTA MARK G · CIK 0001236389 · Director 10b5-1 filing: Plan reported Ownership: Indirect · by Trust Disclosed balance after: 53,871 F3 · ownership.nature: Shares are held by The Foletta Family Trust DTD 1/30/2015, with respect to which the reporting person is a trustee. Read SEC document |
| July 15, 2025 Filed Jul 17, 2025 20:08 UTC |
FOLETTA MARK GDirector
|
SaleCommon Stock | 2,742 | $85.17 | $233,528.46 |
DisclosureSEC source: 0001093557-25-000228 · wk-form4_1752782910.xml · nonDerivative · entry 1 FOLETTA MARK G · CIK 0001236389 · Director 10b5-1 filing: Plan reported Ownership: Indirect · by Trust Disclosed balance after: 53,879 F1 · shares: On March 13, 2025, The Foletta Family Trust DTD 1/30/2015 (the "Trust") adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by the Trust. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $84.815 to $85.44. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| July 15, 2025 Filed Jul 17, 2025 20:03 UTC |
Brown Michael JonEVP, Chief Legal Officer
|
SaleCommon Stock | 500 | $86.03 | $43,015.00 |
DisclosureSEC source: 0001093557-25-000226 · wk-form4_1752782579.xml · nonDerivative · entry 1 Brown Michael Jon · CIK 0001899922 · EVP, Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 94,602 F1 · shares: On February 21, 2025, Mr. Brown adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Brown. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 86,490 unvested restricted stock units, 29,922 of which were granted on March 8, 2025 and shall vest through March 8, 2028, 22,798 of which were granted on March 8, 2025 and shall vest through March 8, 2027, 14,474 of which were granted on March 8, 2024 and shall vest through March 8, 2027, 7,256 of which were granted on March 8, 2023 and shall vest through March 8, 2026, and 12,040 of which were granted on March 8, 2022 and shall vest through March 8, 2026. Read SEC document |
| June 26, 2025 Filed Jun 30, 2025 22:47 UTC |
Stern SadieEVP, Chief HR Officer
|
SaleCommon Stock | 1,466 | $85.06 | $124,697.96 |
DisclosureSEC source: 0001093557-25-000222 · wk-form4_1751323654.xml · nonDerivative · entry 1 Stern Sadie · CIK 0001797971 · EVP, Chief HR Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 108,155 F1 · shares: On February 20, 2025, Ms. Stern adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Ms. Stern. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 74,450 unvested restricted stock units, 29,922 of which were granted on March 8, 2025 and shall vest through March 8, 2028, 22,798 of which were granted on March 8, 2025 and shall vest through March 8, 2027, 14,474 of which were granted on March 8, 2024 and shall vest through March 8, 2027, and 7,256 of which were granted on March 8, 2023 and shall vest through March 8, 2026. Read SEC document |
| June 16, 2025 Filed Jun 17, 2025 21:33 UTC |
AUGUSTINOS NICHOLASDirector
|
SaleCommon Stock | 3,672 | $82.80 | $304,041.60 |
DisclosureSEC source: 0001093557-25-000212 · wk-form4_1750195990.xml · nonDerivative · entry 2 AUGUSTINOS NICHOLAS · CIK 0001238485 · Director 10b5-1 filing: Plan reported Ownership: Indirect · by Trust Disclosed balance after: 33,411 F1 · shares: On March 14, 2025, Mr. Augustinos adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Augustinos. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · ownership.nature: Shares are held by the Kirschner/Augustinos Revocable Trust, with respect to which the reporting person is a trustee. Read SEC document |
| June 16, 2025 Filed Jun 18, 2025 20:31 UTC |
FOLETTA MARK GDirector
|
SaleCommon Stock | 2,750 | $83.13 | $228,604.75 |
DisclosureSEC source: 0001093557-25-000218 · wk-form4_1750278712.xml · nonDerivative · entry 1 FOLETTA MARK G · CIK 0001236389 · Director 10b5-1 filing: Plan reported Ownership: Indirect · by Trust Disclosed balance after: 56,621 F1 · shares: On March 13, 2025, The Foletta Family Trust DTD 1/30/2015 (the "Trust") adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by the Trust. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $82.635 to $83.61. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · ownership.nature: Shares are held by The Foletta Family Trust DTD 1/30/2015, with respect to which the reporting person is a trustee. Read SEC document |
| June 16, 2025 Filed Jun 18, 2025 20:31 UTC |
Brown Michael JonEVP, Chief Legal Officer
|
SaleCommon Stock | 500 | $82.80 | $41,400.00 |
DisclosureSEC source: 0001093557-25-000217 · wk-form4_1750278680.xml · nonDerivative · entry 1 Brown Michael Jon · CIK 0001899922 · EVP, Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 95,102 F1 · shares: On February 21, 2025, Mr. Brown adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Brown. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 86,490 unvested restricted stock units, 29,922 of which were granted on March 8, 2025 and shall vest through March 8, 2028, 22,798 of which were granted on March 8, 2025 and shall vest through March 8, 2027, 14,474 of which were granted on March 8, 2024 and shall vest through March 8, 2027, 7,256 of which were granted on March 8, 2023 and shall vest through March 8, 2026, and 12,040 of which were granted on March 8, 2022 and shall vest through March 8, 2026. Read SEC document |
| June 13, 2025 Filed Jun 17, 2025 21:33 UTC |
AUGUSTINOS NICHOLASDirector
|
SaleCommon Stock | 2,618 | $81.69 | $213,864.42 |
DisclosureSEC source: 0001093557-25-000212 · wk-form4_1750195990.xml · nonDerivative · entry 1 AUGUSTINOS NICHOLAS · CIK 0001238485 · Director 10b5-1 filing: Plan reported Ownership: Indirect · by Trust Disclosed balance after: 37,083 F1 · shares: On March 14, 2025, Mr. Augustinos adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Augustinos. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · ownership.nature: Shares are held by the Kirschner/Augustinos Revocable Trust, with respect to which the reporting person is a trustee. Read SEC document |
| May 27, 2025 Filed May 28, 2025 20:51 UTC |
Stern SadieEVP, Chief HR Officer
|
SaleCommon Stock | 6,184 | $85.11 | $526,318.38 |
DisclosureSEC source: 0001093557-25-000199 · wk-form4_1748465469.xml · nonDerivative · entry 1 Stern Sadie · CIK 0001797971 · EVP, Chief HR Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 109,621 F1 · shares: On February 20, 2025, Ms. Stern adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Ms. Stern. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $84.75 to $85.445. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 74,450 unvested restricted stock units, 29,922 of which were granted on March 8, 2025 and shall vest through March 8, 2028, 22,798 of which were granted on March 8, 2025 and shall vest through March 8, 2027, 14,474 of which were granted on March 8, 2024 and shall vest through March 8, 2027, and 7,256 of which were granted on March 8, 2023 and shall vest through March 8, 2026. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.